ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 83 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17 | +21.4% | 13,098 | -59.6% | 0.00% | +100.0% |
| Q1 2023 | $14 | -99.9% | 32,386 | +118.6% | 0.00% | 0.0% |
| Q3 2022 | $11,000 | -93.5% | 14,812 | -33.9% | 0.00% | -92.3% |
| Q3 2019 | $170,000 | +40.5% | 22,425 | +0.2% | 0.01% | +85.7% |
| Q1 2019 | $121,000 | +202.5% | 22,384 | +66.9% | 0.01% | +250.0% |
| Q4 2018 | $40,000 | – | 13,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 1,510,872 | $800,762 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 122,892 | $65,133 | 0.01% |
| Bernardo Wealth Planning LLC | 38,578 | $20,446 | 0.01% |
| Key FInancial Inc | 7,500 | $5,490 | 0.00% |
| Penserra Capital Management LLC | 215,722 | $114 | 0.00% |
| King Wealth Management Group | 16,000 | $8 | 0.00% |
| Newbridge Financial Services Group, Inc. | 6,075 | $3,220 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,900 | $61,427 | 0.00% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $26,341 | 0.00% |
| Founders Capital Management | 2,000 | $1 | 0.00% |